Westpac Banking Corp’s Charles River Laboratories CRL Stock Holding History

Westpac Banking Corp’s Portfolio CRL Stock Details CRL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$101K	Sell	588 -364	-38%	-$67.5K	0.01%	424
2025 Q4	$190K	Sell	952 -7	-0.7%	-$1.27K	0.01%	361
2025 Q3	$150K	Sell	959 -35	-4%	-$5.56K	0.01%	377
2025 Q2	$151K	Sell	994 -44	-4%	-$5.87K	0.01%	379
2025 Q1	$156K	Sell	1,038 -34	-3%	-$5.7K	0.01%	359
2024 Q4	$198K	Sell	1,072 -44	-4%	-$8.48K	0.01%	370
2024 Q3	$220K	Buy	+1,116	New	+$232K	0.01%	363
2023 Q2	–	Sell	-4,303	Closed	-$868K	–	562
2023 Q1	$868K	Hold	4,303	–	–	0.01%	676
2022 Q4	$938K	Hold	4,303	–	–	0.01%	623
2022 Q3	$847K	Hold	4,303	–	–	0.01%	650
2022 Q2	$921K	Hold	4,303	–	–	0.01%	680
2022 Q1	$1.22M	Hold	4,303	–	–	0.01%	660
2021 Q4	$1.62M	Hold	4,303	–	–	0.02%	613
2021 Q3	$1.78M	Hold	4,303	–	–	0.02%	608
2021 Q2	$1.59M	Buy	+4,303	New	+$1.44M	0.02%	656

Other funds holding CRL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Westpac Banking Corp's CRL Position: Q1 2026 in Review

Westpac Banking Corp reduced its Charles River Laboratories (CRL) stake by 38% in Q1 2026, selling an estimated $67.5K and leaving 588 shares worth $101K. The position accounts for 0.01% of the portfolio, ranked #424.

Westpac Banking Corp first reported a position in CRL in Q2 2021 and has held it in 15 quarters since. The position peaked at $1.78M in Q3 2021. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

Westpac Banking Corp held 588 shares of Charles River Laboratories worth $101K as of Q1 2026.
Westpac Banking Corp sold 364 Charles River Laboratories shares in Q1 2026, an estimated $67.5K.
Charles River Laboratories made up 0.01% of Westpac Banking Corp's portfolio in Q1 2026, its #424 holding.
Westpac Banking Corp first reported a position in Charles River Laboratories in Q2 2021 and has held it in 15 quarters since.
Westpac Banking Corp's Charles River Laboratories position peaked at $1.78M in Q3 2021.
557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Westpac Banking Corp's 13F filing for Q1 2026, filed 12 May 2026.